The primacy of public health considerations in defining poor quality medicines.

PLoS Medicine, 2011; 8(12): e1001139
Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, Simons B, Bate R, Guerin PJ, White NJ
Doi: 10.1371/journal.pmed.1001139  PMID: 22162953

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.